[1] |
Martin MJ, Estravís M, García⁃Sánchez A, et al. Genetics and epigenetics of atopic dermatitis: an updated systematic review[J]. Genes (Basel), 2020,11(4):442. doi: 10.3390/genes11040442.
|
[2] |
Yang G, Seok JK, Kang HC, et al. Skin barrier abnormalities and immune dysfunction in atopic dermatitis[J]. Int J Mol Sci, 2020,21(8):2867. doi: 10.3390/ijms21082867.
|
[3] |
Czarnowicki T, Krueger JG, Guttman⁃Yassky E. Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march[J]. J Allergy Clin Immunol, 2017,139(6):1723⁃1734. doi: 10.1016/j.jaci.2017.04.004.
|
[4] |
路雪艳, 李云珠, 门月华, 等. 特应性皮炎样小鼠模型皮肤屏障功能受损的分子机制研究[J]. 中国麻风皮肤病杂志, 2013,29(3):164⁃167. doi: 10.3969/j.issn.1009⁃1157.2013.03.006.
|
[5] |
Choi JH, Kim HG, Jin SW, et al. Topical application of Pleurotus eryngii extracts inhibits 2,4⁃dinitrochlorobenzene⁃induced atopic dermatitis in NC/Nga mice by the regulation of Th1/Th2 balance[J]. Food Chem Toxicol, 2013,53:38⁃45. doi: 10.1016/j.fct.2012.11.025.
|
[6] |
莫俊銮, 周继昌, 刘小立, 等. DNCB致敏诱导BALB/c小鼠特应性皮炎模型的建立[J]. 中国热带医学, 2013,13(12):1439⁃1442. doi: 10.13604/j.cnki.46⁃1064/r.2013.12.043.
|
[7] |
Choi YY, Kim MH, Lee H, et al. (R)⁃(+)⁃pulegone suppresses allergic and inflammation responses on 2,4⁃dinitrochlorobenzene⁃induced atopic dermatitis in mice model[J]. J Dermatol Sci, 2018,91(3):292⁃300. doi: 10.1016/j.jdermsci.2018.06.002.
|
[8] |
Jung M, Lee TH, Oh HJ, et al. Inhibitory effect of 5,6⁃dihydroergosteol⁃glucoside on atopic dermatitis⁃like skin lesions via suppression of NF⁃κB and STAT activation[J]. J Dermatol Sci, 2015,79(3):252⁃261. doi: 10.1016/j.jdermsci.2015.06.005.
|
[9] |
Wollina U. Microbiome in atopic dermatitis[J]. Clin Cosmet Investig Dermatol, 2017,10:51⁃56. doi: 10.2147/CCID.S130013.
|
[10] |
Murzina E, Kaliuzhna L, Bardova K, et al. Human skin microbiota in various phases of atopic dermatitis[J]. Acta Dermatovenerol Croat, 2019,27(4):245⁃249.
|
[11] |
苏惠春, 姚煦, 王宝玺. 皮肤微生物群与特应性皮炎[J]. 中华皮肤科杂志, 2016,49(10):754⁃757. doi: 10.3760/cma.j.issn. 0412⁃4030.2016.10.028.
|
[12] |
Bradley CW, Morris DO, Rankin SC, et al. Longitudinal evaluation of the skin microbiome and association with microenvironment and treatment in canine atopic dermatitis[J]. J Invest Dermatol, 2016,136(6):1182⁃1190. doi: 10.1016/j.jid. 2016.01.023.
|
[13] |
Moosbrugger⁃Martinz V, Hackl H, Gruber R, et al. Initial evidence of distinguishable bacterial and fungal dysbiosis in the skin of patients with atopic dermatitis or Netherton syndrome[J]. J Invest Dermatol, 2021,141(1):114⁃123. doi: 10.1016/j.jid. 2020.05.102.
|